Therefore, our study demonstrated that FSJ has protective and therapeutic effects in the SCO-induced mouse model of amnesia and may be associated with improvements in hippocampal neurogenesis, in the cholinergic system, and in the signaling pathway that involves BDNF, CREB, and Akt. This evidence concerns the gene AKT1 and amnesia.